Basic information Safety Supplier Related

2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER

Basic information Safety Supplier Related

2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER Basic information

Product Name:
2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER
Synonyms:
  • 2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER
  • Lenalidomide Impurity 16
  • Methyl 2-(broMoMethyl)-4-nitrobenzoate
  • Methyl 2-(bromomethyl)-4-nitrobenzoate 99%
  • Benzoic acid, 2-(bromomethyl)-4-nitro-, methyl ester
  • Lenalidomide Impurity 105
CAS:
133446-99-8
MF:
C9H8BrNO4
MW:
274.07
Mol File:
133446-99-8.mol
More
Less

2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER Chemical Properties

Boiling point:
398.4±37.0 °C(Predicted)
Density 
1.624±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
solid
color 
Off-white
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-43
Safety Statements 
36/37
HS Code 
2916310090
More
Less

2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTER Usage And Synthesis

Uses

Methyl 2-(Bromomethyl)-4-nitrobenzoate is used in the synthetic preparation of cyclic hydroxamic acid derivatives as histone deacetylase inhibitors with antitumor activity.

Synthesis

62621-09-4

133446-99-8

General procedure for the synthesis of methyl 2-(bromomethyl)-4-nitrobenzoate from methyl 2-methyl-4-nitrobenzoate: methyl 2-methyl-4-nitrobenzoate (20 g, 88.01 mmol) was dissolved in carbon tetrachloride (100 mL) in a 500 mL three-necked round-bottomed flask. Subsequently, N-bromosuccinimide (39.16 g, 220.03 mmol) and azobisisobutyronitrile (AIBN, 2.16 g, 13.20 mmol) were added, and the reaction mixture was heated to reflux for 20 hours. Upon completion of the reaction, the reaction was quenched with distilled water (500 mL) and extracted with dichloromethane (200 mL x 3). The organic layers were combined, washed with saturated brine solution and dried over anhydrous sodium sulfate. The organic layers were concentrated under reduced pressure and the crude product obtained was purified by silica gel column chromatography to afford pure methyl 2-(bromomethyl)-4-nitrobenzoate (19 g, 78.7% yield). The structure of the product was confirmed by 1H NMR (400 MHz, DMSO-d6): δ 8.52 (s, 1H), 8.27-8.30 (dd, 1H), 8.07-8.10 (d, 1H), 5.10 (s, 2H), 3.94 (s, 3H).

References

[1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 22, p. 7625 - 7651
[2] Patent: WO2010/139953, 2010, A1. Location in patent: Page/Page column 32
[3] Patent: US2012/115862, 2012, A1. Location in patent: Page/Page column 34-35
[4] Patent: WO2016/81464, 2016, A1. Location in patent: Paragraph 00118
[5] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 250 - 255

2-BROMOMETHYL-4-NITRO-BENZOIC ACID METHYL ESTERSupplier

Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Beijing Eternalchem Co,. Ltd.
Tel
010-59484199 18611897322
Email
sales@eternalchem.com
Daicel Chiral Technologies (China)CO.,LTD
Tel
021-50460086-9 15921403865
Email
han_yajun@dctc.daicel.com
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
Chengdu HappySyn Pharmaceutical Technology Co., Ltd.
Tel
028-85114309 18982182443
Email
yangli@happysyn.com